Skin Test for Cutaneous Adverse Drug Reactions
Downloads
Background: The incidence of drug eruptions is increasing during the last few years due to a large number of new medications. Early detection of the causative agent and the prevention from exposure are crucial managements in terms of drug eruption, mainly to prevent its recurrence. Objective: To understand skin test as a diagnostic modality in drug eruption, which includes skin patch test, skin prick test, and intradermal test. Literature review: Drug eruption is a form of skin eruption triggered by the use of medications, topical or systemic, in the right dose and indication. The manifestation can vary from maculopapular, urticaria, pustular, and bullous eruption; from the most nonsignificant to a life-threatening reaction. A diagnostic procedure is critical to discover the type of drugs that cause the eruption, i.e., skin test, specific IgE measurement, histamine-release test, and provocation test. Skin test is the first choice in the diagnostic process as it is simple, easy, practical and has high sensitivity and specificity. Conclusion: Skin test is one of the many available diagnostic tools. However, both false positive and false negative results might still arise. The experts are currently attempting to come up with more accurate and practical tests to aid the diagnostic of drug eruption, thus preventing its occurrence.
Lachapelle JM. Testing procedures in cutaneous systemic immune-related adverse drug reactions. In:Lachapelle JM, Maibach H, editors. Patch testing and prick testing: a practical guide. New York: Springer-Verlag; 2012. p. 173-85.
Goncalo M, Bruynzeel DP. Patch testing in adverse drug reactions. In:Johansen JD, editor. Contact dermatitis. Berlin-Heidelberg: Springer-Verlag; 2010. p.1-18.
Mahajan VK, Handa S. Patch testing in cutaneous adverse drug reactions: methodology, interpretation and clinical relevance. IJVDL 2013; 79(6):836-41.
Thong BYH, Mirakian R, Castells M, Pichler W, Romano A, Bonadonna P, et al. A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. WAOJ 2011; 4:257-70.
Lehloenya RJ. Cutaneous adverse drug reactions. CME 2011; 29(6):238-42.
Rive CM, Bourke J, Phillips EJ. Testing for drug hypersensitivity syndromes. Clin Biochem Rev 2013; 34:15-38.
Schnyder B, Pichler WJ. Nonimmediate drug allergy: diagnostic benefit of skin testing and practical approach. J Allergy Clin Immunol 2012; 129:1170-1.
Kavadas FD, Kasprzak A, Atkinson AR. Antibiotic skin testing accompanied by provocative challenges in children is a useful clinical tool. AACI Journal 2013; 9(22).
McKay D. Cutaneous allergy. J R Coll Physicians Edinb 2013; 43:241-5.
Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs – an ENDA/EAACI drug allergy interest group. EAACI 2013; 68:702-12.
Abbas AK. Hypersensitivity. In:Abbas AK, Lichtman AH, Pillai S, editors. Basic immunology. Philadelphia: Elsevier Saunders; 2014. p. 207-25.
Clayton T. Patch testing. [Online].; 2016 [cited 2016 May 23. Available from: http://www.dermexpert.co.uk/patch-testing/.
Heinzerling L, Mari A, Bergmann KC, Bresciani M, Burbach G, Darsow U, et al. The skin prick test – European standards. CTA Journal 2013; 3(3).
Niederberger V, Eckl-Dorna J, Pauli G. Recombinant allergen-based provocation testing. Methods 2014; 66: 96-105.
Lachapelle JM, Maibach HI. Methodology of open (non-prick) testing, prick testing and its variants. In:Lachapelle JM, Maibach HI, editors. Patch testing and prick testing. New York: Springer-Verlag; 2012. p. 159-70.
ASCIA. Skin prick testing for the diagnosis of allergic disease : ASCIA 2016.
QAS. Causes and testing. [Online].; 2012 [cited 2016 May 23. Available from: http://www.qldallergy.com/causes-and-testing.
Mahboob A, Haroon TS, Iqbal Z, Saleemi MA, Munir A. Fixed drug eruption and intradermal provocation test. JCPSP 2008;18(12): 736-9.
KCPP. Intradermal testing. [Online].; 2016 [cited 2016 May 23. Available from: http://www.kcallergycenter.com/intradermal-testing.
KMoU. Allergy testing - skin. [Online].; 2014 [cited 2016 May 23. Available from: http://keckmedicine.adam.com/content.aspx?productId=117&pid=1&gid=00519
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
